High impact

Update item information
Publication Type Journal Article
Department Office of Public Affairs, University Health Care
Creator Sample, Susan
Title High impact
Date 2000-03
Description From 1993-97, Gilbert contributed to seven articles published in top peer-reviewed journals, which were then cited 1,157 times, or an average of 165.3 times per paper. When Gilbert heard the news, "it kind of blew me away." He acknowledged that the articles, clinical trials of new drugs to treat chronic heart failure, "are pivotal findings. " As gratifying as the accolades are, Gilbert is proudest of the clinical impact: "Patients now are getting these drugs prescribed because of these papers." About 5 million Americans have chronic heart failure, sometimes referred to as congestive heart failure. Chronic heart failure usually is a progressive condition. Chronic heart failure is on the rise. "It's the most common cause of hospitalization in the elderly," said Gilbert. These hospitalizations cost a total of $8-15 million each year, more than twice the cost of hospitalizations for all forms of cancer. Fortunately, as reported in the high-impact papers, angiotensin-converting enzyme (ACE) inhibitors and beta-adrenergic receptor (beta) blockers not only treat the symptoms of chronic heart failure, but also reverse the progression. "Taken together, these drugs will reduce the annual rate of death from heart failure by 50 percent," said Gilbert.
Type Text
Publisher University of Utah Health Sciences Center
First Page 8
Last Page 10
Subject Chronic Heart Failure; ACE Inhibitors; Beta -Blockers
Subject MESH Heart Diseases
Language eng
Bibliographic Citation Sample,S. High Impact. Health Sciences Report. 2000.24(2);8-10
Rights Management TBD
Format Medium application/pdf
Identifier ir-main,676
ARK ark:/87278/s6db8k6f
Setname ir_uspace
Date Created 2012-06-13
Date Modified 2021-05-06
ID 704505
Reference URL https://collections.lib.utah.edu/ark:/87278/s6db8k6f
Back to Search Results